CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.
A summary of key findings of CADTH reports assessing the available evidence on pharmacological, psychological and alternative options for the treatment of PTSD.
The CADTH pan-Canadian Oncology Drug Review (pCODR) undertakes rigorous, objective reviews of cancer drugs and provides funding recommendations to Canada’s provinces and territories (except Quebec). Funders use this information as one element of their decision-making process to determine if a drug will be eligible for public reimbursement. ...